NOVOPEN Echo Plus Insulin Pen

Product Information

Manually logging data is time consuming. It typically did not show the exact time that insulin was administered, for example, before or after a meal was consumed. Smart connected devices reduce this time spent logging and provide more precise data.” Roche expects Novo Nordisk insulin pen data will sync to the mySugr app and Accu-Chek SmartPix software. For mySugr Bundle users, coaches will now get injection history alongside other diabetes data. NovoPen® 6 and NovoPen Echo® Plus are insulin injection pens that record dosing information, including when and how much insulin was administered.

Novo Nordisk two smart insulin pens available on prescription

Novo Nordisk has announced that the NovoPen® 6 and NovoPen Echo® Plus are both now available on prescription for individuals with diabetes who are treated with Novo Nordisk insulin in the UK.

Long-acting insulin types, brands and pens

Commenting on the interoperability between the smart pens and FreeStyle LibreLink, James says: “I have found registering NovoPen devices onto the LibreLink app very simple for myself and people in my clinic. Technology is rapidly changing the way we manage and live with diabetes, mainly Type 1 diabetes, and is enabling us to manage our condition better and achieve better long-term outcomes. The availability of new technologies, such as Smart Insulin pens, further enables us to achieve better clinical and quality of life outcomes each day and is a welcome diabetes tool in Ireland”, said Dr Kate Gajewska, Clinical Manager for Advocacy and Research, Diabetes Ireland. Providing your smartphone or tablet supports Near Field Communication (NFC) then Novo’s smart pens can be connected with the following apps:

Instructions for use - Novo Nordisk

A further analysis looking at missed bolus doses (insulin that is specifically taken at mealtimes) indicated that NovoPen® 6 decreased the average daily number of missed doses by 43% (p=0.002) by the end of the study. Digital health tools such as the smart insulin pen will improve diabetes management by empowering patients with data”, Professor Derek O’Keeffe, Consultant Endocrinologist at University Hospital Galway (UHG), and Professor of Medical Device Technology at the National University of Ireland Galway.When your pancreas is working properly it makes small amounts of insulin all the time and releases more insulin when your blood glucose levels increase after eating. When you have diabetes, your body does not make enough insulin or the insulin it makes does not work properly. Emma Wilmot, consultant diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust said: “Integrating innovative technology as a routine part of diabetes care is an important step to improve diabetes care. Novo Nordisk’s smart connected pens are an example of how technology can support people living with diabetes to gain greater insight into the management of their diabetes, on their journey to becoming experts in their diabetes. In my clinic, the opportunity to view daily insulin data will allow me to better support the individual with diabetes to achieve their goals. It will allow for more tailored and informed advice on optimisation of glucose levels, with the ultimate goal of improving future outcomes.” Long-acting insulin starts to work after 30 minutes to 4 hours, depending on the type. It usually lasts for 16 to 24 hours, depending on the type and your dose. You'll usually take it once or twice a day. It's a good idea to carry medical identification such as an insulin safety card or insulin passport – a small card with up-to-date details of the type of insulin you use, and what to do in an emergency.

NovoPen 6 and NovoPen Echo Plus: Connected Insulin Pens To NovoPen 6 and NovoPen Echo Plus: Connected Insulin Pens To

Pinder Sahota, general manager, Novo Nordisk UK, said: “We believe digital innovation of devices and treatments has the potential to transform people’s lives and help alleviate the daily burden of living with diabetes. Our smart connected insulin pens aim to empower people to better understand their diabetes management, have more informed conversations with their doctor and ultimately improve their blood glucose control.” This change to the interoperability meant all my data was now in one place. You can see sugar levels, insulin taken and add any extra notes for food and exercise.” How significant are smart insulin pens as a tech development? On interoperability with connective devices, Dr Griffin says: “Traditionally a person living with diabetes could see their glucose data in one place and would have needed to keep a manual log of their insulin data – often on paper or on a different platform. Insulin is a hormone made in your pancreas, which is a gland behind the stomach. It helps your body use glucose (sugar) for energy.

Novo Nordisk’s smart connected pens are an example of how technology can support people living with diabetes to gain greater insight into the management of their diabetes, on their journey to becoming experts in their diabetes.” NovoPen ® 6 and NovoPen Echo ® Plus smart insulin pens collect dose data and time and date of dose to better inform the management of diabetes alongside blood glucose monitoring. Once your smart insulin pen is connected to an integrated app, this information can then be sent virtually to help people manage their insulin data more easily and in one place. I have been using an insulin pump for just over six months now, but before then I was using Novo smart pens. I would use the Echo Plus for my rapid-acting insulin injections, and the NovoPen 6 for my long-acting insulin. The two smart connected insulin pens now allow healthcare professionals to view the insulin dosing information of people with diabetes, helping to facilitate more productive consultations and support personalised treatment guidance.